Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI.

× No keyword cloud information.

14 in total

1. Clot formation by group A streptococci.

Authors: H Donabedian; M D Boyle
Journal: Infect Immun Date: 1998-05 Impact factor: 3.441

2. Antithrombin III activity (residual thrombin activity) in plasma from non-medicated or heparinized horses.

Authors: B J Darien; J Potempa; J N Moore; J Travis
Journal: Vet Res Commun Date: 1989 Impact factor: 2.459

3. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.

Authors: B Ghebrehiwet; B P Randazzo; J T Dunn; M Silverberg; A P Kaplan
Journal: J Clin Invest Date: 1983-05 Impact factor: 14.808

4. Binding of factors IX and IXa to cultured vascular endothelial cells.

Authors: D M Stern; M Drillings; H L Nossel; A Hurlet-Jensen; K S LaGamma; J Owen
Journal: Proc Natl Acad Sci U S A Date: 1983-07 Impact factor: 11.205

5. Purified human plasma kallikrein aggregates human blood neutrophils.

Authors: M Schapira; E Despland; C F Scott; L A Boxer; R W Colman
Journal: J Clin Invest Date: 1982-05 Impact factor: 14.808

6. The activation of the alternative pathway C3 convertase by human plasma kallikrein.

Authors: R G DiScipio
Journal: Immunology Date: 1982-03 Impact factor: 7.397

7. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.

Authors: C F Scott; L D Silver; M Schapira; R W Colman
Journal: J Clin Invest Date: 1984-04 Impact factor: 14.808

Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI.